Impact of Pathological Stratification on the Clinical Outcomes of Advanced Well-Differentiated/Dedifferentiated Liposarcoma Treated with Trabectedin.

导出 OA

翻译打印收藏纠错

作者： Chiara,Fabbroni ^[1] ; Giovanni,Fucà ^[1] ; Francesca,Ligorio ^[1] ; Elena,Fumagalli ^[1] ; Marta,Barisella ^[2] ; Paola,Collini ^[2] ; Carlo,Morosi ^[3] ; Alessandro,Gronchi ^[4] ; Angelo Paolo,Dei Tos ^[5] ; Paolo Giovanni,Casali ^[6] ; Roberta,Sanfilippo ^[1]

作者单位： Adult Mesenchymal Tumour Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy. ^[1] Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy. ^[2] Department of Radiology, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy. ^[3] Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy. ^[4] Department of Pathology and Molecular Genetics, Treviso General Hospital, 31100 Treviso, Italy. ^[5] Department of Medicine, University of Padova School of Medicine, 35128 Padova, Italy. ^[6] Oncology and Hemato-Oncology Department, University of Milan, 20122 Milan, Italy. ^[7]

关键词 chemotherapy grading liposarcoma soft tissue sarcoma trabectedin

DOI 10.3390/cancers13061453

PMID 33810165

发布时间 2021-04-08

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交